Variant report
Variant | rs11241352 |
---|---|
Chromosome Location | chr5:115412283-115412284 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000272265 | Chromatin interaction |
ENSG00000145781 | Chromatin interaction |
ENSG00000271918 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10036669 | 0.89[AFR][1000 genomes];0.92[AMR][1000 genomes];0.94[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs10042177 | 0.95[CHB][hapmap];0.95[JPT][hapmap] |
rs10043670 | 0.83[AFR][1000 genomes];0.91[AMR][1000 genomes];0.90[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs10051072 | 0.95[CHB][hapmap];0.95[JPT][hapmap] |
rs10051302 | 0.95[CHB][hapmap];0.95[JPT][hapmap] |
rs10056823 | 0.86[CEU][hapmap] |
rs10059455 | 0.89[AFR][1000 genomes];0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs10063312 | 0.82[CEU][hapmap];0.95[CHB][hapmap];0.94[JPT][hapmap] |
rs10065178 | 0.84[AFR][1000 genomes];0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs10065554 | 0.91[AFR][1000 genomes];0.95[AMR][1000 genomes];0.95[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs10066081 | 0.95[CHB][hapmap];0.95[JPT][hapmap] |
rs10068479 | 0.89[AFR][1000 genomes];0.92[AMR][1000 genomes];0.94[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs10075063 | 0.83[CEU][hapmap];0.95[CHB][hapmap];0.94[JPT][hapmap];0.92[AMR][1000 genomes];0.93[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs10075195 | 0.83[CEU][hapmap];1.00[CHB][hapmap];0.95[JPT][hapmap];0.82[YRI][hapmap];0.89[AFR][1000 genomes];0.99[AMR][1000 genomes];0.96[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs10077013 | 0.90[CHB][hapmap];0.95[JPT][hapmap] |
rs10078121 | 0.84[CHB][hapmap] |
rs10079176 | 0.83[CEU][hapmap];0.95[CHB][hapmap];0.95[JPT][hapmap];0.92[AMR][1000 genomes];0.93[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs10079466 | 0.95[CHB][hapmap];0.95[JPT][hapmap] |
rs10079691 | 0.82[CEU][hapmap];0.95[CHB][hapmap];0.94[JPT][hapmap] |
rs10079903 | 0.84[AFR][1000 genomes];0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs10463453 | 0.95[CEU][hapmap];0.90[CHB][hapmap];0.85[JPT][hapmap];1.00[YRI][hapmap];0.98[AFR][1000 genomes];0.92[AMR][1000 genomes];0.88[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs10463676 | 0.92[AMR][1000 genomes];0.94[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs11241359 | 0.85[AFR][1000 genomes];0.92[AMR][1000 genomes];0.92[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs11241360 | 0.83[AFR][1000 genomes];0.84[AMR][1000 genomes];0.83[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs11241374 | 0.82[CEU][hapmap];0.95[CHB][hapmap];0.94[JPT][hapmap] |
rs11241375 | 0.95[CHB][hapmap];0.95[JPT][hapmap] |
rs1129494 | 0.86[CEU][hapmap];0.95[CHB][hapmap];0.94[JPT][hapmap];0.93[AFR][1000 genomes];0.95[AMR][1000 genomes];0.95[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs1133187 | 0.85[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.99[AMR][1000 genomes];0.95[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs11738674 | 0.92[AMR][1000 genomes];0.94[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs11738775 | 0.88[AMR][1000 genomes];0.93[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs11742938 | 0.95[CHB][hapmap];0.95[JPT][hapmap] |
rs11746600 | 0.92[AMR][1000 genomes];0.90[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs11750725 | 0.81[AMR][1000 genomes] |
rs11950936 | 0.89[AFR][1000 genomes];0.92[AMR][1000 genomes];0.94[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs11952043 | 0.81[AFR][1000 genomes];0.92[AMR][1000 genomes];0.94[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs11958648 | 0.84[AFR][1000 genomes];0.92[AMR][1000 genomes];0.94[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs12054994 | 0.95[CHB][hapmap];0.94[JPT][hapmap] |
rs12656463 | 0.84[AFR][1000 genomes];0.92[AMR][1000 genomes];0.94[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs12657249 | 0.82[CEU][hapmap];0.95[CHB][hapmap];0.94[JPT][hapmap] |
rs13153586 | 0.82[AMR][1000 genomes];0.84[EUR][1000 genomes] |
rs13157583 | 1.00[CEU][hapmap];0.95[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs13159102 | 0.95[CHB][hapmap];0.95[JPT][hapmap] |
rs13161987 | 0.89[CHB][hapmap];0.95[JPT][hapmap] |
rs13162238 | 0.89[AFR][1000 genomes];0.94[AMR][1000 genomes];0.94[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs13172482 | 0.83[CEU][hapmap];0.95[CHB][hapmap];0.95[JPT][hapmap];0.92[AMR][1000 genomes];0.94[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs13179593 | 0.85[AFR][1000 genomes];0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs13182605 | 0.92[AMR][1000 genomes];0.91[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs13184073 | 0.89[AFR][1000 genomes];0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs1396478 | 0.83[CEU][hapmap];0.95[CHB][hapmap];0.95[JPT][hapmap];0.92[AMR][1000 genomes];0.93[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs1396479 | 0.91[AMR][1000 genomes];0.94[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs1396481 | 0.95[CHB][hapmap];0.94[JPT][hapmap] |
rs1396482 | 0.95[CHB][hapmap];0.95[JPT][hapmap] |
rs1508875 | 0.82[CEU][hapmap];0.95[CHB][hapmap];0.94[JPT][hapmap] |
rs1508882 | 0.92[AMR][1000 genomes];0.93[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs1588267 | 0.83[CEU][hapmap];0.95[CHB][hapmap];0.94[JPT][hapmap];0.81[YRI][hapmap];0.85[AFR][1000 genomes];0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs1669135 | 0.82[CEU][hapmap];0.95[CHB][hapmap];0.89[JPT][hapmap] |
rs1669136 | 0.83[CEU][hapmap];0.95[CHB][hapmap];0.84[JPT][hapmap] |
rs1677405 | 0.83[CEU][hapmap] |
rs2063249 | 0.91[AMR][1000 genomes];0.87[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs2063250 | 0.89[AFR][1000 genomes];0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs2221676 | 0.92[AMR][1000 genomes];0.92[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs2416426 | 0.84[AFR][1000 genomes];0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs2416427 | 0.86[AFR][1000 genomes];0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs253959 | 0.86[CEU][hapmap];0.89[CHB][hapmap];0.94[JPT][hapmap] |
rs4383750 | 0.98[AMR][1000 genomes];0.95[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs4921062 | 0.92[AMR][1000 genomes];0.93[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs4921063 | 0.92[AMR][1000 genomes];0.93[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs6594938 | 0.83[CEU][hapmap];0.95[CHB][hapmap];0.95[JPT][hapmap];0.82[YRI][hapmap];0.89[AFR][1000 genomes];0.95[AMR][1000 genomes];0.94[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs6594948 | 0.95[CHB][hapmap];0.95[JPT][hapmap] |
rs6865237 | 0.92[AMR][1000 genomes];0.90[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs6871968 | 0.91[AMR][1000 genomes];0.89[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs6876901 | 0.83[CEU][hapmap];0.95[CHB][hapmap];0.94[JPT][hapmap];0.83[AFR][1000 genomes];0.95[AMR][1000 genomes];0.92[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs6879929 | 0.95[AMR][1000 genomes];0.94[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs6886944 | 0.86[JPT][hapmap];0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs6889212 | 0.92[AMR][1000 genomes];0.91[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs6894046 | 0.94[CHB][hapmap];0.94[JPT][hapmap];0.93[AFR][1000 genomes];0.95[AMR][1000 genomes];0.95[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs6896479 | 0.86[CEU][hapmap];0.95[CHB][hapmap];0.94[JPT][hapmap];0.86[YRI][hapmap];0.91[AFR][1000 genomes];0.98[AMR][1000 genomes];0.94[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs712561 | 0.95[CHB][hapmap];0.90[JPT][hapmap] |
rs7703164 | 0.91[AMR][1000 genomes];0.92[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs7715797 | 0.90[AMR][1000 genomes];0.83[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs7723358 | 0.80[CEU][hapmap] |
rs7728838 | 0.82[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs7729414 | 0.82[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs7730551 | 0.86[CEU][hapmap];0.95[CHB][hapmap];1.00[JPT][hapmap];0.98[AMR][1000 genomes];0.95[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs7734295 | 0.85[AFR][1000 genomes];0.95[AMR][1000 genomes];0.93[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs7735539 | 0.82[CEU][hapmap];0.95[CHB][hapmap];0.94[JPT][hapmap] |
rs803967 | 0.83[CEU][hapmap];0.90[CHB][hapmap];0.85[JPT][hapmap] |
rs9326986 | 0.93[AFR][1000 genomes];0.97[AMR][1000 genomes];0.95[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs9326987 | 0.86[CEU][hapmap];0.95[CHB][hapmap];0.94[JPT][hapmap];0.86[YRI][hapmap];0.89[AFR][1000 genomes];0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];0.93[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv949677 | chr5:115104829-115496168 | Enhancers Weak transcription Active TSS Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 40 gene(s) | inside rSNPs | diseases |
2 | nsv1027418 | chr5:115206256-115446861 | Enhancers Weak transcription Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 26 gene(s) | inside rSNPs | diseases |
3 | nsv515611 | chr5:115208843-115428381 | Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers Active TSS Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 23 gene(s) | inside rSNPs | diseases |
4 | nsv1021968 | chr5:115213162-115426468 | Strong transcription Flanking Active TSS Weak transcription Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Active TSS Transcr. at gene 5' and 3' Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 23 gene(s) | inside rSNPs | diseases |
5 | nsv1024008 | chr5:115222974-115431050 | Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS Strong transcription Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 23 gene(s) | inside rSNPs | diseases |
6 | nsv1027117 | chr5:115222974-115442883 | Active TSS Enhancers Weak transcription Bivalent Enhancer Strong transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 23 gene(s) | inside rSNPs | diseases |
7 | esv2763487 | chr5:115222986-115442895 | Flanking Active TSS Strong transcription Enhancers Weak transcription Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 23 gene(s) | inside rSNPs | diseases |
8 | nsv462400 | chr5:115223504-115428381 | Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 23 gene(s) | inside rSNPs | diseases |
9 | nsv599478 | chr5:115223504-115428381 | Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS Bivalent Enhancer Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 23 gene(s) | inside rSNPs | diseases |
10 | nsv1030480 | chr5:115228889-115446861 | Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription Strong transcription Flanking Bivalent TSS/Enh Active TSS Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 23 gene(s) | inside rSNPs | diseases |
11 | nsv599479 | chr5:115233116-115450969 | ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Strong transcription Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 23 gene(s) | inside rSNPs | diseases |
12 | nsv1015976 | chr5:115236239-115434163 | Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Strong transcription Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 23 gene(s) | inside rSNPs | diseases |
13 | nsv537868 | chr5:115236239-115434163 | Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Strong transcription Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 23 gene(s) | inside rSNPs | diseases |
14 | nsv882736 | chr5:115254723-115552945 | Weak transcription Bivalent/Poised TSS Bivalent Enhancer Enhancers Strong transcription Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 25 gene(s) | inside rSNPs | diseases |
15 | nsv882737 | chr5:115263853-115552945 | Flanking Active TSS Weak transcription Strong transcription Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 25 gene(s) | inside rSNPs | diseases |
16 | esv34146 | chr5:115315944-115729919 | Flanking Active TSS Enhancers ZNF genes & repeats Weak transcription Strong transcription Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 29 gene(s) | inside rSNPs | diseases |
17 | nsv527320 | chr5:115382097-115573543 | Enhancers Weak transcription ZNF genes & repeats Flanking Active TSS Strong transcription Active TSS Transcr. at gene 5' and 3' Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 20 gene(s) | inside rSNPs | diseases |
18 | nsv1027266 | chr5:115382704-115501792 | Weak transcription Active TSS Strong transcription Enhancers Flanking Active TSS ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 18 gene(s) | inside rSNPs | diseases |
19 | esv2755349 | chr5:115384101-115733101 | Active TSS Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Strong transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 24 gene(s) | inside rSNPs | diseases |
20 | nsv1032199 | chr5:115384131-115525738 | Enhancers Strong transcription Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 19 gene(s) | inside rSNPs | diseases |
21 | esv2830404 | chr5:115386661-115490546 | Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 17 gene(s) | inside rSNPs | diseases |
22 | nsv1019972 | chr5:115386860-115563533 | Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 19 gene(s) | inside rSNPs | diseases |
23 | nsv537869 | chr5:115386860-115563533 | Strong transcription Enhancers Active TSS Weak transcription Flanking Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 19 gene(s) | inside rSNPs | diseases |
24 | nsv1018861 | chr5:115397834-115563533 | Active TSS Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Strong transcription Transcr. at gene 5' and 3' Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 17 gene(s) | inside rSNPs | diseases |
25 | nsv537870 | chr5:115397834-115563533 | Weak transcription Enhancers Strong transcription ZNF genes & repeats Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 17 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:115405400-115419600 | Weak transcription | Fetal Brain Male | brain |
2 | chr5:115410600-115419400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr5:115410800-115413200 | Enhancers | Primary B cells from peripheral blood | blood |
4 | chr5:115411000-115413200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr5:115411000-115419600 | Weak transcription | Fetal Intestine Small | intestine |
6 | chr5:115411000-115419600 | Weak transcription | Pancreas | Pancrea |
7 | chr5:115411200-115412600 | Enhancers | GM12878-XiMat | blood |
8 | chr5:115411400-115413400 | Enhancers | Primary monocytes fromperipheralblood | blood |
9 | chr5:115411400-115419600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr5:115411600-115413000 | Enhancers | Primary B cells from cord blood | blood |
11 | chr5:115411600-115413000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr5:115411600-115413200 | Enhancers | Primary hematopoietic stem cells | blood |
13 | chr5:115411600-115413400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
14 | chr5:115411600-115419400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr5:115411600-115419400 | Weak transcription | K562 | blood |
16 | chr5:115411600-115419600 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
17 | chr5:115412000-115412400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
18 | chr5:115412200-115413000 | Enhancers | Primary T helper cells PMA-I stimulated | -- |